论文部分内容阅读
尽管神经显微外科技术高速发展,肿瘤的切除率不断上升,放疗及化疗的敏感性也大幅度提高,但胶质瘤的预后并没有提高。随着肿瘤干细胞的提出,给胶质瘤的研究带来新方向;对胶质瘤干细胞的研究可能是未来对胶质瘤研究的一个主导方向,而胶质瘤干细胞标志物的研究是该研究的基础。
Despite the rapid development of neurosurgical microsurgery technology, tumor resection rate continues to rise, the sensitivity of radiotherapy and chemotherapy has also increased significantly, but the prognosis of gliomas did not increase. With the advance of tumor stem cells, it will bring a new direction for the study of gliomas. The study of glioma stem cells may be one of the leading directions for glioma research in the future, and the study of glioma stem cell markers is the research Foundation.